Effect of Obesity on Left Ventricular Mass and Systolic Function in Patients With Asymptomatic Aortic Stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] Substudy)

American Journal of Cardiology

Volumn 105, Issue 10, 2010, Pages 1456-1460

  Lund, Barbara P ^a   Gohlke Bärwolf, Christa ^b   Cramariuc, Dana ^a   Rossebø, Anne B ^c   Rieck, Åshild E ^d   Gerdts, Eva ^a,d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; PLACEBO; SIMVASTATIN;

AGED; AGING; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC VALVE STENOSIS; AZETIDINES; BODY MASS INDEX; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME;

EID: 77951665802     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.069     Document Type: Article

References (30)

1. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., and Eckel R.H. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 113 (2006) 898-918
2. Burwash I.G., Forbes A.D., Sadahiro M., Verrier E.D., Pearlman A.S., Thomas R., Kraft C., and Otto C.M. Echocardiographic volume flow and stenosis severity measures with changing flow rate in aortic stenosis. Am J Physiol 265 (1993) 1734-1743
3. Devereux R.B., de Simone G., Ganau A., and Roman M.J. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl 12 (1994) 117-127
4. Cramariuc D., Rieck A.E., Staal E.M., Wachtell K., Eriksen E., Rossebø A.B., and Gerdts E. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). Am J Cardiol 101 (2008) 510-515
5. Chambers J., Takeda S., Rimington H., Lambert-Hammill M., Shetty C., and Wierzbicki A. Determinants of left ventricular mass in aortic stenosis. J Heart Valve Dis 13 (2004) 873-880
6. Rossebø A.B., Pedersen T.R., Allen C., Boman K., Chambers J., Egstrup K., Gerdts E., Gohlke-Bärwolf C., Holme I., Kesäniemi V.A.Y., Malbecq W., Nienaber C., Ray S., Skjærpe T., Wachtell K., and Willenheimer R. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol 99 (2007) 970-973
7. Rossebø A.B., Pedersen T.R., Boman K., Brudi P., Chambers J.B., Egstrup K., Gerdts E., Gohlke-Bärwolf C., Holme I., Kesäniemi Y.A., Malbecq W., Nienaber C.A., Ray S., Skjærpe T., Wachtell K., and Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359 (2008) 1343-1356
8. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., Sutton M.S.J., and Stewart W. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
9. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
10. de Simone G., Daniels S.R., Devereux R.B., Meyer R.A., Roman M.J., de Divitiis O., and Alderman M.H. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20 (1992) 1251-1260
11. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., and Laragh J.H. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19 (1992) 1550-1558
12. Gaasch W.H., Zile M.R., Hoshino P.K., Apstein C.S., and Blaustein A.S. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 79 (1989) 872-883
13. de Simone G., Devereux R.B., Roman M.J., Ganau A., Saba P.S., Alderman M.H., and Laragh J.H. Assessment of left ventricular function by midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 23 (1994) 1444-1451
14. Wachtell K. Left ventricular systolic performance in asymptomatic aortic stenosis. Eur Heart J 10 Suppl E (2008) 16-22
15. Bella J.N., Palmieri V., Roman M.J., Paranicas M.F., Welty T.K., Lee E.T., Fabsitz R.R., Howard B.V., and Devereux R.B. Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study). Am J Cardiol 98 (2006) 834-837
16. Jones E.C., Devereux R.B., Roman M.J., Liu J.E., Fishman D., Lee E.T., Welty T.K., Fabsitz R.R., and Howard B.V. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 87 (2001) 298-304
17. Lebowitz N.E., Bella J.N., Roman M.J., Liu J.E., Fishman D.P., Paranicas M., Lee E.T., Fabsitz R.R., Welty T.K., Howard B.V., and Devereux R.B. Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study. J Am Coll Cardiol 36 (2000) 461-467
18. Pi-Sunyer F.X., Becker D.M., Bouchard C., Carleton R.A., Colditz G.A., Dietz W.H., Foreyt J.P., Garrison R.J., Grundy S.M., Hansen B.C., Higgins M., Hill J.O., Howard B.V., Kuczmarski R.J., Kumanyika S., Legako R.D., Prewitt T.E., Rocchini A.P., Smith P.L., Snetselaar L.G., Sowers J.R., Weintraub M., Williamson D.F., and Wilson G.T. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 68 (1998) 899-917
19. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D.W., and Otto C.M. Clinical factors associated with calcific aortic valve disease. J Am Coll Cadiol 29 (1997) 630-634
20. Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., Ernst N.D., and Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Rev 8 (2000) 605-619
21. Wang W., Lee E.T., Fabsitz R.R., Devereux R.B., Best L., Welty T.K., and Howard B.V. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension 47 (2006) 403-409
22. Ingelsson E., Sullivan L.M., Fox C.S., Murabito J.M., Benjamin E.J., Polak J.F., Meigs J.B., Keyes M.J., O'Donnell C.J., Wang T.J., D'Agostino R.B., Wolf P.A., and Vasan R.S. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 116 (2007) 375-384
23. de Simone G., Devereux R.B., Roman M.J., Alderman M.H., and Laragh J.H. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 23 (1994) 600-606
24. Lieb W., Xanthakis V., Sullivan L.M., Aragam J., Pencina M.J., Larson M.G., Benjamin E.J., and Vasan R.S. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham Offspring Study. Circulation 119 (2009) 3085-3092
25. Messerli F.H. Cardiopathy of obesity: a not-so-Victorian disease. N Engl J Med 314 (1986) 378-380
26. Ku C.S., Lin S.L., Wang D.J., Chang S.K., and Lee W.J. Left ventricular filling in young normotensive obese adults. Am J Cardiol 73 (1994) 613-615
27. Roman M.J., Pickering T.G., Schwartz J.E., Pini R., and Devereux R.B. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 28 (1996) 751-756
28. Gerdts E., Cramariuc D., de Simone G., Wachtell K., Dahlöf B., and Devereux R.B. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 9 (2008) 809-815
29. Chinali M., de Simone G., Roman M.J., Lee E.T., Best L.G., Howard B.V., and Devereux R.B. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 47 (2006) 2267-2273
30. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., Flachskampf F., Hall R., Iung B., Kasprzak J., Nataf P., Tornos P., Torracca L., and Wenink A. Guidelines on management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268